Quantitative Monitoring of Circulating Epstein-Barr Virus DNA for Predicting the Development of Posttransplantation Lymphoproliferative Disease
- 1 April 2001
- journal article
- case report
- Published by Springer Nature in International Journal of Hematology
- Vol. 73 (3) , 323-326
- https://doi.org/10.1007/bf02981956
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Epstein‐Barr Virus (EBV) Load and Cytokine Gene Expression in Activated T Cells of Chronic Active EBV InfectionThe Journal of Infectious Diseases, 2001
- Epstein-Barr virus (EBV) load in bone marrow transplant recipients at risk to develop posttransplant lymphoproliferative disease: prophylactic infusion of EBV-specific cytotoxic T cellsBlood, 2000
- Epstein–Barr virus-associated lymphoproliferative disease after a cord blood transplant for Diamond–Blackfan anemiaBone Marrow Transplantation, 2000
- Simultaneous ex vivo expansion of cytomegalovirus and Epstein-Barr virus-specific cytotoxic T lymphocytes using B-lymphoblastoid cell lines expressing cytomegalovirus pp65.1999
- Rapid titer determination using quantitative real-time PCRGene Therapy, 1999
- Persistently High Epstein‐Barr Virus (EBV) Loads in Peripheral Blood Lymphocytes from Patients with Chronic Active EBV InfectionThe Journal of Infectious Diseases, 1999
- Immunodeficiency-associated lymphoproliferative disorders.1999
- Clinical and pathological features of post-transplant lymphoproliferative disorders (PTLD)Springer Seminars in Immunopathology, 1998
- Post-Transplant EBV Induced Lymphoproliferative DisordersLeukemia & Lymphoma, 1997
- Pretransplantation Assessment of the Risk of Lymphoproliferative DisorderClinical Infectious Diseases, 1995